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Abstract
The development of a nucleic acid (deoxyribonucleic acid (DNA), ribonucleic acid
(RNA)) bioassay based on magnetic nanoparticles (MNPs) with a high-T c supercon-
ducting quantum interference device (SQUID) gradiometer as a magnetic readout is
described. The specific binding of the MNPs to the target DNA molecules changes
the MNPs size distribution and, therefore, the relaxation dynamics and is measured
by magnetic ac susceptometry. The binding reactions are measured by SQUID gra-
diometer in a microfluidic channel with volume of 3 µL. The magnetic content sen-
sitivity at the noise level of our SQUID is estimated to be 1.5× 106 MNPs/√Hz or
2.9× 10−10 emu/√Hz in magnetic moment, corresponding to 2.5 ng of MNPs with
diameter of 100 nm.
Two different assay protocols are investigated for a magnetic nucleic acid biosensor.
Padlock probes with suitable sequences are used as bioreceptors and circularize upon
target recognition. The rolling circle amplification (RCA) provides the gain to the
target molecule by copying the circularized padlock probe into a large concatemer.
The specific binding of the MNPs to these large DNA coils changes their relaxation
dynamics. These large DNA molecules can also digest into short monomers. The
monomers can induce an agglutination if two MNP with matching sequence motifs
to the two ends of the monomer are introduced. The agglutinated clusters would
have large hydrodynamic size, thus, a different relaxation dynamics. The bioassay
has shown higher sensitivity using large DNA coils. Extrapolated sensitivity of the
sensor to target analyte is estimated to be 66 fM of RCA coils. This is limit is
equivalent to 1.0× 105 target DNA molecules.
The method and instruments that are adopted and presented here are not limited
to the Vibrio cholera bioanalyte and are generic and could in principle be used for
other DNA or RNA viruses. The ultra-high magnetic sensitivity combined with the
microfluidic sample handling is a critical step towards a magnetic bioassay for rapid
detection of diseases at the point-of-care (POC). Future developments include imple-
mentation of all steps of the bioassay on a disposable lab-on-chip and eliminating the
liquid nitrogen by operating the SQUID on a micro-cooler platform. These would
make the magnetic bioassay promising for applications as a future nano-diagnostics
unit.
Keywords: magnetic bioassay, biosensor, high-T c SQUID, rolling circle amplification,
magnetic nanoparticle, diagnostics.
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1
Aim and outline
In this thesis, we describe the development of a sensitive magnetic nucleic acid bioas-
say based on magnetic nanoparticle (MNP) labels using high-T c superconducting
quantum interference device (SQUID) gradiometer readout and microfluidic sample
handling. Padlock probe ligation is exploited for target recognition followed by an
amplification method, rolling circle amplification (RCA). The detection of the target
is based on the immobilization of MNP labels on RCA products and is measured
using magnetic ac susceptibility. The development is a part of the FLU-ID project
supported by the Swedish Foundation for Strategic Research, SSF. The ultimate goal
of the project is development of a portable nano-diagnostics unit for detection of pan-
demic influenza. The unit should have high specificity and sensitivity, low cost, and
fast response.
The thesis is divided into three main parts: the first chapter describes the details of
different elements of nucleic acid assay, namely the target recognition, amplification
and the specific binding to biomarkers and the relaxation processes associated with
MNPs which are used for detection of the target analyte. The second chapter gives
a short introduction into the principles of operation of the SQUID and presents the
SQUID gradiometer sensor developed for this project. In order to have better control
over the volume and geometry of the samples, microfluidic channels are used. The
basics and fabrication of the microfluidic chip is explained. The experimental ac
susceptibility setup is then described following a model that simulates the flux from
the ferrofluidic samples inside the microfluidic chips coupling to the pick-up loops of
the SQUID gradiometer. Chapter 4 covers the measurements of MNPs and the RCA
products both in form of large RCA coils and short digested monomers. Chapter 5
summarizes the performance and sensitivity of the assay and the detection method
and gives an outlook on future work towards a point-of-care (POC) nano-diagnostic
unit.
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2
Biomagnetic assay
Biosensors are analytical devices utilizing the high sensitivity and selectivity of bi-
ological sensing. They are comprised of two main components: (I) a bioreceptor
and (II) signal transduction. Bioreceptors are biological recognition elements that
discriminate and distinguish the target analyte, e.g. antigen/antibody, deoxyribonu-
cleic acid (DNA), cell, etc. The biorecongnition is not necessarily measurable and
therefore, a signal transduction is necessary. Signal transduction is a process which
translates the biological signal into a measurable physical signal. Numerous signal
transduction methods are used in biosensors: fluorescence [4], electrochemistry [5],
Raman scattering [6], field effect transistors [7], magnetoresistance [8], planar hall
sensors [9], magnetic susceptibility [10] just to name a few. There is a diverse variety
of biosensors combining different biological recognition elements with different signal
transduction methods.
Nucleic acid assays are a group of biosensors that adopt DNA as bioreceptor. They
use a single-strand DNA which hybridizes to its complementary strand with good
specificity to realize the detection of a specific DNA or ribonucleic acid (RNA) target.
These nucleic acid-based sensors can be used to detect pathogens, infection diseases
etc. Functionalized nucleic acids like aptamers and DNA enzymes have broadened the
applications to detect inorganic and organic molecules and even organisms [11]. The
nucleic acid assays are simple and accurate due to the DNA hybridization technique
and therefore, have attracted a lot of attention leading to new developments and
technologies. The sensitivity of these biosensors depends mainly on three factors:
the efficiency of the sequence hybridization, the sequence amplification method, and
sensor sensitivity. The hybridization efficiency is affected by the structure of the
probe and target, the hybridization condition and molecular interactions, etc. [12].
The sequence amplification is a necessary step to reach sensitivities that are required
in diagnostic laboratories. There are several amplification methods available, such
as polymerase chain reaction (PCR) [13], loop mediated isothermal amplification
(LAMP)[14], ligase chain reaction (LCR)[15], and RCA[16]. Many of the above
mentioned signal transduction methods, e.g. fluorescence, electrochemistry, etc.,
among others are currently used in the nucleic acid assays. However, sensitive signal
transduction is still one of the bottlenecks biosensors face in practical applications.
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Recent developments in nanotechnology have allowed the use of nanostructures such
as nanoparticles, nanotubes, nanowires, etc. in biosensors. MNPs have a wide range
of applications in biology and medicine [17, 18, 19]. The developments in the synthesis
and coatings of MNPs [20] have given them a biological recognition function. MNPs
are now used as labels for detection, mobile substrates for binding to target analyte
or both as substrate and label at the same time [21]. Bioassays based on MNPs have
the advantage of real-time detection and low level of background signal. They also do
not require immobilization or intermediate washing steps making them advantageous
for biosensing [22].
2.1 Nucleic acid assay
The genetic information encoded as a sequence of monomers in nucleic acids, DNA
and RNA, are responsible for cellular function and consequently essential for all forms
of life. The building block monomers are nucleotides which are made of a 5-carbon
sugar, a phosphate group and a nitrogenous base. Nucleic acid diagnostics measure
DNA or RNA in order to assay a particular nucleic acid sequence. To detect low
abundant nucleic acids, numerous methods have been developed which selectively
copy a specific and pre-defined nucleic acid sequence [23, 24].
The first and most commonly used nucleic acid amplification method is PCR. It is
simple, easy, and has been broadly validated. The PCR technique relies on thermal
cycling of the reaction for replication and amplifies a specific target DNA sequence to
large number of copies. Despite all its advantages, PCR has its limitations, such as
chances of contamination, sensitivity to certain contaminants, inhibitors, and thermal
cycling [25].
There are several alternative amplification methods to PCR that offer potential ad-
vantages for speed, scale, cost and simplicity, e.g. LAMP[14], LCR[15], and RCA[16].
In our bioassay we are using the RCA technique for amplification. RCA is an isother-
mal amplification and enables enzymatic amplification of the probe-target complex.
The biomolecular detection technique utilizes a highly specific hybridization reaction
between a probe molecule and a matching target forming a probe-target complex.
This proves to be advantageous for genotyping or mutation detection in a unrelated
background. The probe-target complex can then be amplified in order to achieve
high sensitivity in single-molecule detection [25, 26].
The probes are synthetic linear oligonucleotides containing target complimentary
regions at the ends. Upon conjugation with matching DNA target, the two ends of
the probe are brought together forming a circularized padlock probe. Probes are
then closed by ligation. The ligation is sensitive to any mismatch at the 3′ end of
the probe molecule. The circular probes are extended by continuous progression of
Φ29 DNA polymerase around the padlocks turning them into long single stranded
concatemer DNA molecules. These large DNA molecules (also called DNA coils)
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contain complementary sequences of the circular probe-target complex, Fig. 2.1.
Throughout this work, synthetic Vibrio cholera target DNA is used. The DNA
sequences used in this study for Vibrio cholera target, padlock probe and detection
oligonucleotide are presented in Table 2.1. The procedure which has been used to
produce final RCA products of 5 nM concentration is explained in the following
sections.
Table 2.1: DNA sequences used in this study for synthetic target Vibrio cholera,
the padlock probe and the detection oligonucleotide.
Target Vibrio cholera 5′-CCC TGG GCT CAA CCT AGG AAT CGC ATT
TG-3′
Padlock probe for
Vibrio cholera
5′-TAG GTT GAG CCC AGG GAC TTC TAG AGT
GTA CCG ACC TCA GTA GCC GTG ACT ATC GAC
TTG TTG ATG TCA TGT GTC GCA CCA AAT GCG
ATT CC-3′
Detection oligonu-
cleotide
5′-Biotin-TTT TTT TTT TTT TTT TTT TTG TTG
ATG TCA TGT GTC GCAC-3′-FAM
2.1.1 Padlock probe target recognition and ligation
The padlock probe is a synthesized linear oligonucleotide, typically consisting of 70-
100 nucleotides in length [27]. Around 20 outermost nucleotides at both 3′ and 5′ ends
of the padlock are sequences complementary to the target DNA sequence. Therefore,
they hybridize to the target DNA sequence in juxtaposition. The rest of the sequence
linking the two hybridization arms are used for detection and identification.
In order to form a probe-target complex, 3 µl synthesized target Vibrio cholera DNA
(1 µM) was hybridized and ligated at 37 ◦C for 15 minutes with 1 µl padlock probe
(1 µM) in a solution consisting of 2.5 µl of 20 mM adenosine triphosphate (ATP),
1 µl T4 DNA ligase (1U/µl, enzyme unit per micro liter), and 5 µl of Φ29 DNA
polymerase buffer in a total volume of 50 µl. After the probes are conjugated to
the targets, a ligase mediated process closes the snick in between the two ends and
topologically locks the padlock to the target. The ligation process is very sensitive to
any mismatch at the 3′ end of the padlock probe molecule. This allows an excellent
sequence probing and detects any mutations down to single nucleotide [28, 29].
2.1.2 Amplification
The circularized padlocks are then amplified by continuous progression of Φ29 poly-
merase around the circular DNA padlock probe replicating its sequence. In order to
amplify the padlock probes, 25 µl ligation mix consisting of 20 nM concentration of
padlock probes are copied by 0.4 µl Φ29 polymerase for 1 hour at 37 ◦C in a solu-
tion with 4 µl nucleotide triphosphate (dNTP) (2.5 mM), 6 µl bovine serum albumin
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(a) Hybridization of the target 
DNA with padlock probe
(b) Ligation
T4
(d) Functionalization of MNPs
with oligonucleotides
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Figure 2.1: Illustration of (a) padlock probe recognition of synthetic Vibrio cholera
target DNA , (b) ligation, (c) the amplification of the probes by RCA and (d) func-
tionalized MNP for specific binding to the RCA coils. The oligonucleotide tags are
bound to the streptavidin shell of the MNPs by a biotin molecule.
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(BSA) (2 µg/ml), 6 µl Φ29 polymerase buffer and water in 60 µl reaction volume.
The enzyme is thermally inactivated at 65◦C for 5 minutes. A hybridization buffer of
1 M Tris(hydroxymethyl) aminomethane hydrochloride (Tris-HCl) (pH 8.0), 0.5 M
ethylenediaminetetraacetic acid (EDTA), Tween-20(10%) and 5M sodium chloride
(NaCl) was added at the end [30]. The one hour reaction produces approximately
1000 complimentary copies of the circularized probe-target complex, joining them
end-to-end within a single DNA macromolecule [29].
2.1.3 Oligonucleotide tagged MNP probes
The RCA products need to be labeled before they can be detected. They are detected
optically or magnetically by addition of fluorescent or magnetic labels, respectively.
The labels have complementary oligonucleotides to linking part of the base sequence
RCA products which allow them to hybridize with the DNA coils. This results
in crowding the labels around the DNA coils which can be detected optically or
magnetically. In this work streptavidin-coated MNPs are used as physical labels for
detection. A biotin molecule is added to the detection oligonucleotide and the high
affinity of streptavidin for biotin binds the oligonucleotides to the MNPs. On the
other end of the detection oligonucleotide there is also a fluorescent label which allows
optical detection of the DNA coils, Fig. 2.1.
The coupling of the oligonucleotides to the MNPs is performed in a volume of 100 µl.
The MNPs are washed twice using a magnetic separator in a washing buffer with 1
M Tris-HCl (pH 8.0), 0.5 M EDTA, polysorbate 20 (Tween-20)(10%) and 5 M NaCl.
The MNPs are then re-suspended in 50 µl washing buffer. 6 µl of the oligonucleotide
with 1 µM concentration is added to the re-suspended MNPs and the mixture is
vortexed and incubated at room temperature for 15 minutes. After the incubation
the MNPs are washed again in the washing buffer for two times and re-suspended to
the original volume of 100 µl in phosphate-buffered saline (PBS) with a pH of 7.4.
With the oligonucleotides bound to the surface, the MNPs are functionalized and
can specifically bind to the backbone of the padlock probe amplified by the RCA
method.
2.1.4 Detection
In order to detect the RCA products the MNP or fluorescence tags should hybridize
to the RCA coils. The functionalized MNPs, tagged with the oligonucleotides, are
conjugated to the RCA products by mixing the two samples and incubated the mix
for 20 minutes at 55 ◦C. During the hybridization the sample volume should be kept
small in order to increase the chance of the tags and the RCA coils to meet. The
samples are then brought to the final desired volume and concentration by adding
hybridization buffer solution.
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2.1.5 Theoretical and determined RCA concentration
The sample preparation method that is described above gives a theoretical concentra-
tion of 5 nM for the RCA products. This value is estimated from the concentration
of the padlock probes specified by the vendor. In a recent study by Kühnemund et
al. [31], the final concentration of the RCA products in a solution has been deter-
mined experimentally. This study shows that the actual number of the products is
only 22.6% of the theoretical number. The discrepancy is related to the imprecise
determination of the concentration by the vendors, inefficiencies during ligation and
amplification reactions.
2.1.6 Monomerized RCA coils
Unlike the PCR method, the RCA amplification is linear and the products are all con-
tained in one continuous DNA molecule. This limited amplification is not sufficient
for many applications. However, the circle-to-circle amplification (C2CA) mecha-
nisms can be used to amplify the circular DNA strands without increasing the target
analyte concentration [32]. By RCA, a first round of amplification generates large
products containing repeated copies of the probe compliment. Through restrictive
digestion these large products are cut into monomers. These monomers can then be
circularized and ligated for a second round of RCA. An hour of amplification results
in 1000 copies of a typical 100 nucleotide long DNA circle. Thus, one cycle of C2CA
generates 1000 RCA coils [28]. The C2CA can be preformed several times to achieve
a high concentration of RCA coils. Furthermore, the monomerized RCA products
can also be used for the detection of the target analyte. The digested RCA prod-
ucts are mixed with two MNP probes with matching motifs on two separate parts of
the padlock probe backbone. The presence of the monomers induces agglutination
between the two MNP probes by linking them together [33]. The agglutination pro-
cess aggregates the particles and results in a change in the hydrodynamic size of the
MNPs which is detectable through measuring the characteristic relaxation times of
the MNPs.
2.2 Magnetic nanoparticles as labels
MNPs are used in a broad field of application including physics, biology and medicine.
They are increasingly used in biosensors for their unique properties. They are cheap,
biocompatible and have physical and chemical stability [34]. Most biomedical ap-
plications of MNPs are thanks to appropriate coating of MNPs with materials that
are biocompatible and allow bio-functionalization of the MNPs. A few examples of
coatings are polymers, proteins, peptides, oxides, etc [35]. The MNPs we use in our
experiments are water/PBS suspended multi-core Fe2O3 particles with median di-
ameters of 80 and 100 nm. They are prepared via a core-shell method which embeds
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the core magnetite in a non-magnetic shell of hydroxyethyl starch which is a biopoly-
mer material. The coating of these core-shell MNPs with streptavidin enables the
bio-functionalization of the MNPs with oligonucleotides.
The specific binding of the functionalized MNPs to the products of the assay, coils
or monomers, results in a change in their hydrodynamic size. This change in the
hydrodynamic size affects the dynamic properties of the suspended MNP. The effec-
tive relaxation time of the MNPs generally describes the dynamics of the particles
relating it to the hydrodynamic size, viscosity as well as anisotropy energy [36]. In
this section we describe the magnetic relaxation mechanism for the MNPs and ac
susceptibility as a method to measure these characteristic relaxation times.
2.2.1 Magnetic relaxation processes
The response of a ferromagnetic material to sudden changes of an external magnetic
field shows a time lag. Applying a varying magnetic field to a system of suspended
nanoparticles gives rise to relaxation processes that are different from bulk materials.
There are two mechanisms responsible for the relaxation of the magnetization of
magnetic nanoparticles suspended in a liquid, Fig. 2.2: The Brownian relaxation
where the MNPs change their magnetic orientation through a stochastic rotation
of the particle itself and the Néel relaxation where the magnetic moment of the
particle changes its orientation within the particle overcoming the energy barrier due
to anisotropy energy. The time decay associated with rotational diffusion is described
by Brownian relaxation time, τB :
τB =
3ηVhydro
kBT
(2.1)
where η is the viscosity of the carrier fluid, Vhydro = 34pir3H is the hydrodynamic
volume of the particle including the core and its shell, kB is the Boltzman constant,
and T is the temperature. The Néel relaxation time, τN is given by:
τN = τ0 exp(
KVp
kBT
) (2.2)
where τ0 is a material specific characteristic relaxation time, and KVp is the energy
barrier between different directions of easy magnetization.
The Néel relaxation time changes the observed magnetic behaviour of the system with
respect to the characteristic experimental measurement time τexp. If τexp  τN , the
system reaches a thermodynamic equilibrium as the relaxation is faster than the
magnetization orientation observed. The nanoparticles are then considered to be
in a superparamagnetic state. However, for τexp  τN , the particle system is in
thermally blocked regime and the magnetization will maintain its direction leading
to a quasistatic state in the measurement time window.
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(a) (b)
Figure 2.2: Illustration of magnetic nanoparticles relaxation mechanisms: (a) Brow-
nian relaxation due to rotation of the suspended MNP in liquid and (b) Néel relax-
ation caused by reorientation of the magnetic moment inside the MNP.
The effective relaxation time is, therefore, a combination of the two characteristic
times:
1
τeff
= 1
τN
+ 1
τB
(2.3)
and is dominated by the process with the shortest relaxation time. Solving τN = τB ,
for the dimension of the suspended particle determines a critical diameter for the
superparamagnetic state [37]:
dcritical = 3
√
6τ0kBT
3piη exp
KVp
kBT
(2.4)
below and above which the Néel and Brownian relaxation processes are the dominat-
ing ones, respectively.
The specific binding of the MNP to the target analyte in our bioassay is detectable
through measuring the MNPs’ relaxation time. The immobilization of MNPs on large
DNA coils changes their hydrodynamic size and according to Eq.(2.1), their Brownian
relaxation time. Therefore, the Brownian relaxation should be the dominant process
in the suspended MNP system we intend to use in our experiments. In order to
assure this, several requirements must be satisfied [37, 38]:
• The thermal energy, kBT , should not exceed the magnetic anisotropy energy
barrier, KVp, of a single particle. If the thermal energy exceeds the energy
barrier that separates the easy directions of magnetization, the magnetization
will switch direction and give rise to zero net magnetization.
• The diameter of the particles should be larger than the critical diameter,
dcritical, so that the effective relaxation time is essentially dominated by the
Brownian relaxation mechanism.
• Comparing the experimental measurement time with the relaxation of internal
magnetic moment, τexp should be shorter than τN , in order to distinguish the
thermally blocked and superparamagnetic particles.
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2.2.2 Ac susceptibility
The Debye theory describes the frequency dependence of complex susceptibility of
dispersive materials, such as polar molecules and ferrofluids [39]. This theory holds
for spherical particles when the magnetic dipole-dipole interaction is negligible com-
pared to the thermal fluctuations. According to the Debye model, magnetization of
a collection of mono-dispersed, non-interaction particles is given by complex suscep-
tibility [40]:
m(ω) = χ(ω)Hac,
χ(ω) = χ0 − χ∞1 + iωτ0 + χ∞
(2.5)
where m(ω) is the complex magnetization, Hac is the applied ac magnetic field, τ0
is the characteristic relaxation time, χ(ω) = χ′(ω)− iχ′′(ω) is the complex dynamic
susceptibility and χ∞ is the high frequency susceptibility. Therefore, the real and
imaginary parts of the complex susceptibility are given by:
χ′ = χ0 − χ∞1 + (ωτ0)2 + χ∞, (2.6)
χ′′ = (χ0 − χ∞)ωτ01 + (ωτ0)2 . (2.7)
The real part of the susceptibility decreases with increasing frequency where the
imaginary part has a maximum at ωτ0 = 1. Assuming that the relaxation process
is dominated by the Brownian relaxation process we can assign τ0 = τB . Fig. 2.3
illustrate the complex susceptibility for 3 particle systems with various particle size
that have the Brownian relaxation as the characteristic relaxation process. According
to Eq.(2.1), the Brownian characteristic time of these particles depends on their
hydrodynamic volume. Therefore, the particle system with greater size (volume) has
a longer relaxation time.
In practice, the colloidal magnetic particles have a particle radii distribution. The
complex susceptibility then becomes:
χ(ω) =
∫
χ0
1 + iωeff (rH)
f(rH)drH (2.8)
where the f(rH)drH is the number of particles with radius between rH and rH +drH
[41]. One commonly used model for the size distribution of the magnetic particles is
the so called lognormal distribution:
f(rH) =
1√
2pirH ln σ
exp[− (ln rH − ln r¯H)
2
2 ln2 σ
] (2.9)
11
2. Biomagnetic assay
Frequency
C
o
m
p
le
x
 s
u
sc
ep
ti
b
il
it
y
d3
d2
d1
Figure 2.3: Complex magnetic susceptibility for samples with 3 different particle
sizes. The imaginary part of the susceptibility maximizes as the frequency approaches
the Brownian relaxation frequency for each particle, ωBτB = 1. Increasing the
hydrodynamic diameter of the particles (d1 < d2 < d3) shifts the relaxation dynamics
to lower frequencies (ω1 > ω2 > ω3) and vice versa.
where r¯H is the median hydrodynamic radius and σ is the standard deviation [42,
43]. By experimentally measuring the complex susceptibility χ(ω), it is possible to
estimate the distribution of the relaxation time and the particle radii [44].
2.2.3 Cole-Cole plot
Experimental results for the ferrofluid material show that the dispersion of frequency
dependent complex susceptibility obeys the following empirical formula:
χ(ω) = χ0 − χ∞1 + (iωτ0)1−α (2.10)
where τ0 is the generalized relaxation time, and α can assume values between 0 and
1. Therefore, the real and imaginary part of the complex susceptibility is given by
χ′ = χ∞ + 12(χ0 − χ∞)[1−
sinh(1− α)x
cosh(1− α)x+ cos 12αpi
], (2.11)
χ′′ =
1
2 (χ0 − χ∞) cos 12αpi
cosh(1− α)x+ sin 12αpi
(2.12)
where x = ln(ωτ0) [45]. This equation was developed by two brothers Kenneth
and Robert Cole in 1941 [45]. The Cole model can be regarded as a superposition
of multiple Debye models with the central relaxation time given by the inverse of
frequency of the peak position on the imaginary part of the susceptibility. This
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Figure 2.4: (a) Real and (b) imaginary part of complex susceptibility versus fre-
quency for the Debye model Eq.(2.5) and the Cole-Cole model Eq.(2.10). The solid
blue curves represent the Debye model and the red and green dashed lines the Cole-
Cole model with different α = 0.1 and α = 0.5 parameters, respectively.
equation reduces to the Debye formula Eq.(2.5) for α = 0. For values of parameter
α greater than 0, the maximum value of the peak χ′′ decreases and the dispersion
broadens. Therefore, the α parameter represents the broadness of the relaxation time
distribution, Fig. 2.4.
The Kramers-Kronig relations relate the real and imaginary part of the complex
susceptibility. Since χ′ and χ′′ are the conjugate functions, it has been shown that
they can be uniquely determined if either one is known over the frequency range [45]:
χ′(ω) = χ∞ + 2
pi
∫ ∞
0
χ′′(ν)νdν
ω2 − ν2 ,
χ′′(ω) = − 2
pi
∫ ∞
0
(χ′(ν)− χ∞)ωdν
ω2 − ν2 .
(2.13)
2.3 Magnetic readout
There are various magnetic readout schemes developed for biosensors utilizing MNPs
as labels. These methods are based on different techniques and measure either the
magnetic permeability to detect the presence of the MNPs, the variation in the hy-
drodynamic properties of the MNPs, the magnetic flux density change or the change
of nuclear spin procession of protons surrounding the MNPs by nuclear magnetic
resonance[18]. These techniques are used together with miscellaneous bioreceptors
for magnetic biosensing.
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Methods based on the variation of the hydrodynamic properties of MNPs use two of
the most important characteristic properties of the MNPs: the magnetic signal and
the relaxation times. The relaxation mechanisms are affected by the hydrodynamic
size of the MNPs and several methods such as magnetic ac susceptibility and magnetic
relaxation have been developed to detect this variation. Biodetection by magnetic ac
susceptibility was first proposed theoretically by Connolly and St Pierre [41] and was
shown experimentally for prostate-specific antigen (PSA) and Brucella antibodies
[10, 46]. The detection of the analyte was determined by measuring the change in
Brownian relaxation time of the MNPs due to their binding to the target. Many
different sensors have been developed that utilize the same principle for detection:
SQUIDs [47, 48], differential induction coil system DynoMag (RISE Acreo, Sweden)
[10, 30], and opto-magnetic sensors [49, 50]. Some of the magnetic relaxation sensors
based on Brownian relaxation have demonstrated promising sensitivities for POC
diagnostics. High-T c SQUID sensors are widely used for their extreme sensitivity to
magnetic field and their operating temperature. Using a high-T c SQUID gradiometer
our group has previously demonstrated that in a one-step assay using multi-core
particles of 100 nm diameter, we were able to detect PSA molecules with ultimate
concentration of 0.7 nM within a 2µL droplet [51, 52]. In this experiment, the
biomolecule detection method was an antigen-antibody binding reaction. Chieh et
al. [53] developed a magnetoreduction assay that measures the variations in the
magnetic properties of marker MNPs under external multiple AC magnetic field
excitation to detect the biotarget. Using rf SQUID readout and dextran coated MNP
functionalized with c-reactive protein (CRP) antibodies, they have demonstrated an
extreme sensitivity of 10−6 mg/l to human CRP which is 105 times better than the
sensitivity of enzyme-linked immunosorbent assay (ELISA) assays. There have also
been reports of using the magnetic ac susceptibility measurement technique as a
signal transduction method for nucleic acid assays. Examples of this are the volume-
amplified magnetic nanobead detection assay using high-T c SQUIDs [54] and the
detection of the Vibrio cholera target DNA binding reaction with functionalized
MNPs using the commercially available differential induction based high frequency
ac susceptometer DynoMag [55]. These results suggest that a sensitive magnetic
bioassay can be realized by the right combination of a bio-recognition method and a
sensitive magnetic readout.
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In order to reach a very high sensitivity for the bioassay we need to have a sensi-
tive magnetic sensor. SQUIDs are among the most sensitive magnetic field sensors.
Therefore, we have developed a SQUID sensor for magnetic measurement of the
bio-functionalized MNPs (magnetic markers) in our bioassay. The immobilization
of the MNPs to the targets analytes changes their hydrodynamic size. According
to Eq. (2.1), this change in size of the MNP affects the Brownian relaxation time.
Magnetic ac susceptometry is frequency domain measurement technique and pro-
vides high resolution information about the relaxation time and size distribution of
the MNPs. In this chapter we describe different components of the experimental
set-up used for measuring the ac susceptibility. The set-up consists of a liquid ni-
trogen cryostat to maintain the high-T c SQUID sensor at 77 K, a Helmholtz coil
to apply external field, an alignment frame for aligning the magnetic field of the
Helmholtz coil and a 3D-printed frame for controlling the position of the microfluidic
chip above the sensor. The basic principle of the SQUID gradiometer sensor used
for magnetic ac susceptometry is explained and the SQUID performance in terms
of noise is provided. Microfluidic chips are used to control the sample volume and
facilitate sample handling. Sec. 3.2 describes the basics and fabrication of the mi-
crofluidic chip. The complete ac susceptibility measurement set-up is described in
Sec. 3.3. Finally, simulations of the flux threading the pick-up loops from the fer-
rofluidic sample are presented and used to study the effect of loop area and channel
position.
3.1 Magnetic readout using a high-Tc gradiometer
The 1987 Nobel prize in physics was awarded to J. Georg Bednorz and K. Alexander
Müller for the discovering the first high temperature superconductor (HTS) with a
transition temperature Tc of 35 K. The same year came the breakthrough of obtaining
superconductivity beyond the 77 K, boiling point of liquid nitrogen. The supercon-
ductivity in the yttrium barium copper oxide, YBa2Cu3O7−δ (YBCO) compound
system was discovered with Tc = 93 K [56]. Reproducibility, high quality films and
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the low price and abundance of liquid nitrogen as the refrigerant are the most signif-
icant advantages of the YBCO superconductor making it one of the most commonly
used high-T c superconductors today. This section describes the basic principle, op-
eration and performance of the high-T c SQUID gradiometer, which is used in our
biomagnetic read out set-up.
3.1.1 dc-SQUID
Josephson junctions are active devices in superconductive electronics. They consist
of two superconductors separated by a weak link. The weak link should only allow a
slight overlap of the electron pair wave function of the two superconductors. There
are many ways to form these weak links in HTS. Three of the most standard methods
are bicrystal grain boundary junctions, step-edge junctions and ramp edge junctions
[57]. The Josephson relations govern the behavior of such a device [58]:
I = Ic sin(φ)
∂φ
∂t
= 2e
~
V = 2piΦ0
V
(3.1)
where Ic is the critical current, φ is the superconducting phase difference across the
junction, e is the electron charge and Φ0 = h2e = 2× 10−15 Wb is the flux quantum.
Since the phase difference across the weak link can be varied by the magnetic field
passing through it, the critical current depends also on the magnetic field or the flux
threading the junction :
Ic(Φ) = Ic(0)| sin(piΦ/Φ0)(piΦ/Φ0) |, (3.2)
where Ic(0) is the maximum critical current. The total critical current as a function
of applied flux is plotted in Fig. 3.1.
The dc-SQUID is a superconducting loop which contains two Josephson junctions
and combines the flux quantization and Josephson effects, Fig. 3.2. The relation
between the phase differences across the two junctions changes if a magnetic flux
is threading the loop. Therefore, similar to the single Josephson junction the total
critical current of the dc SQUID is a function of applied flux in the superconducting
loop, Fig. 3.2 (b). Assuming the critical current of the two junctions to be the same,
Ic1 = Ic2 = Ic, and the SQUID inductance is negligible, the total critical current
becomes:
ITc(Φ) = 2Ic| cos(piΦΦ0 )|. (3.3)
A typical current-voltage characteristic of a dc SQUID in an external magnetic flux
is illustrated in Fig. 3.3(a). Here we have the two extreme cases where the values
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Figure 3.1: Dependency of the Josephson junction critical current on external
applied flux.
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Figure 3.2: (a) A dc SQUID with two Josephson junction interrupting the super-
conducting ring. (b) The dependence of total critical current of a dc SQUID on
external magnetic flux.
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Figure 3.3: (a) The current-voltage characteristics of a dc SQUID for integer and
half-integer multiples of applied flux quantum
;(b) voltage versus applied external flux for an applied constant bias current, with
Ic1 = Ic2.
of applied flux is integer or half-integer. To operate the SQUID, a constant bias
current Ib is applied. If the SQUID bias current is slightly higher than the critical
current of the SQUID, Ib > Ic, the junctions are in the voltage state (a voltage
appears across the junctions), while the critical current of the junctions is modulated
by the external flux. In this case, any change in the applied external flux induces
a screening current that adds to the bias current through the junctions. When the
applied flux reaches half a flux quantum, Φ = Φ0/2, we are at the minimum critical
current of the SQUID and a flux quantum enters into the ring changing the direction
of the screening current. As the external flux increases to a flux quantum the critical
current reaches its maximum again. The voltage drop across the SQUID in turn
swings between the two extreme cases as a function of external flux with period of
Φ0, Fig. 3.3(b). SQUID is therefore a flux-to-voltage transducer and the maximum
response to a small change in the applied flux is obtained where the flux-voltage
transfer function VΦ ≡ |(∆V/∆Φext)Ib | is at a maximum.
3.1.2 dc SQUID gradiometer
A wide range of input circuits can be coupled to the dc SQUIDs for various ap-
plications. In order to measure extremely weak magnetic fields a flux pick-up loop
configured as a magnetometer or gradiometer is coupled to the SQUID. Both the
SQUID magnetometer and gradiometer are only sensitive to the variation of the
magnetic field rather than measuring the absolute field strength. For our biomag-
netic measurements, we would like to operate the SQUID outside a magnetically
18
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Figure 3.4: The layout of the fabricated gradiometer with 3.6 mm baseline. The
width of the pick-up loops are 400 µm. The red dashed line indicates the bicrys-
tal grain boundary, which creates the Josephson junctions in the superconducting
SQUID loop. The SQUID loop has 4 µm wide striplines and the length and width
of the slit are 50 µm and 3 µm, respectively.
shielded room and apply a homogeneous magnetic field from a Helmholtz coil in the
vicinity of the SQUID. Therefore, the gradiometer layout is more appropriate option
for a sensor because it allows the magnetic field source to be close to the SQUID and
it discriminates against distant magnetic sources.
The layout of our SQUID gradiometer is shown in Fig. 3.4. The baseline of the
gradiometer, connecting the center of the two superconducting pick-up loops, is 3.6
mm. The screening currents induced by a homogeneous field in each of the two pick-
up loops cancel each other in the center line of the loop. The SQUID is placed in the
center of the middle line. The SQUID is directly connected to the pick-up loops and
therefore can sense only the difference in magnetic flux in them. The SQUID is made
from bicrystal grain boundary junction in YBCO film; the fabrication technology is
comprehensively described in earlier work [59, 60].
3.1.3 SQUID readout
Since the SQUID has a non-linear voltage-flux response, it has to be operated in a
so called flux locked loop (FLL) readout scheme. The SQUID is flux biased using an
external coil at a working point where the slope of the voltage to flux modulation is
the steepest. In order to lock the SQUID at this working point, the output voltage of
the SQUID is amplified and a flux is fed back into the SQUID through an integrator,
a feedback resistor (Rf ) and via a feedback coil inductively coupled to the SQUID.
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Figure 3.5: Basic flux locked loop circuit with direct readout of the SQUID. The
SQUID voltage is amplified and integrated and is sent back to the feedback coil which
is inductively coupled to one of the gradiometer loops. The output voltage measured
across the feedback resistor is proportional to the feedback current that keeps the
total flux in the SQUID loop constant. The voltage therefore, linearly depends on
the applied flux. Components which are at liquid nitrogen temperature are inside
the dashed box.
The feedback flux compensates the applied external flux signal to the SQUID and the
voltage across the feedback resistor gives the output voltage (Vout) that now depends
linearly on the applied external flux signal, Fig. 3.5.
The performance of the SQUID at low frequencies, however, may be limited by
1/f noise. There are two major contributors to the 1/f noise in HTS SQUIDs:
one is the motion of trapped flux in the superconducting film and the other one is
fluctuations of the critical current in the Josephson junctions. The former can be
minimized by improving the pinning of the vortices inside the superconductor and
to avoid vortex penetration. The later is the dominant source of low-frequency noise
in high-T c SQUIDs. The critical current fluctuations appear either as a voltage
across the SQUID or as a flux in the SQUID and are defined as in-phase and out-of-
phase contributions. The flux modulation readout with constant bias current easily
suppresses the in-phase contribution, while the out-of-phase fluctuations remains a
problem as it cannot distinguish applied flux from the out-of-phase fluctuations. The
two can be discriminated by reversing the bias current. When the SQUID is positively
biased, the applied flux and out-of-phase fluctuations have the same effect, however,
they show an opposite effect for reversed bias current. Therefore, by applying a bias
current reversal scheme which switches between positive and negative bias current,
the net effect of the out-of-phase fluctuations can be eliminated on every period of
bias reversal [57].
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Figure 3.6: (a) Flux modulated IV characteristics of the SQUID with a critical
current of 170 µA at 77 K. The maximum voltage modulation is 16 µV. (b) Flux
noise of the SQUID gradiometer measured inside a magnetically shielded room. The
blue curve with the high 1/f noise was measured using dc-bias. The low frequency
noise is suppressed by using bias reversal as can be seen in the red curve.
3.1.4 Sensor performance
The SQUID gradiometer chip is glued on to a sapphire rod in direct contact with
the liquid nitrogen bath and electrically connected to the amplifiers through a break-
up box. The cryostat is placed inside a magnetically shielded room and the I-V
characteristics of the SQUID are measured. Fig. 3.6(a) shows the flux-modulated
I-V characteristics of the SQUID. The flux noise of the SQUID gradiometer is also
measured inside the magnetically shielded room in dc bias and bias reversal modes.
The best white noise level achieved for this device is 12 µΦ0/
√
Hz. As can be seen
in Fig. 3.6(b), the 1/f noise due to critical current fluctuations is suppressed in the
bias reversal mode.
3.2 Fabrication of microfluidic channels
Microfluidic technology has shown the potential to significantly improve the diagnos-
tic research. There are many advantages in using microfluidics specially for standard
laboratory set-ups, e.g. sample processing and precise control of fluids. This is ex-
tremely important particularly when small sample quantities are available for tradi-
tional experimental bio-analysis approaches. Handling small volume of samples make
it possible to develop systems that are more compact and portable, and promises the
automation of chemistry and biology [61, 62].
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There are different materials that are used to fabricate microfluidic devices for in-
stance, poly(dimethylsiloxane) (PDMS), silicon, glass, etc. We have chosen PDMS
for our microfluidic chip for its fast, easy and cost effective fabrication process. It
is nontoxic, biocompatible, durable and flexible, which makes it a great candidate
for future POC developments [63]. PDMS devices are fabricated using soft lithogra-
phy. There are different methods to fabricate the master mold for casting replicas,
such as photolithography, wet etching, wet/dry silicon etching, etc. Since the mi-
crofluidic devices being used here are rather simple and have large features, precision
machining has been used to fabricate the microfluidic devices. The main advantage
of this technique is the fast transfer of a computer aided design (CAD) into a finished
device. The elastomeric material PDMS, is used as the casting material, which is
very flexible, cheap, nontoxic and easy to handle [64]. The molecular chains in the
elastomer are long and entangles but show no chemical interaction. The structure
of the channel is precision machined into a master aluminum piece and many copies
of the device are made from the same mold with good accuracy using the elastomer
PDMS. Fig. 3.7 shows the dimensions of the microchannel with 1 × 1 mm2 channel
cross-section and a photograph of completely fabricated chip.
Before the microfluidic channel is functional the chips are required to be closed. The
molding creates a PDMS replica with three of the four walls necessary to have an
enclosed channel and since we would like the samples to be as close as possible to the
sensor, a thin layer of PDMS is used to close the channels. A 100 µm thin layer is
spin coated on a silicon wafer and heat cured. Then the capping layer and the PDMS
replica are put together to close the channel since surface adhesion of the PDMS is
normally sufficient to create a good contact. To make sure we have a tightly enclosed
channel that does not leak under pressure, the two surfaces of the PDMS and the
capping layer are primed in oxygen plasma before they are brought into contact. This
process increases the bonding strength and can lead to a permanent bond between
the two by forming covalent bonds [65].
3.3 Ac susceptibility set-up
The following section describes different parts of the the experimental set-up for the
biomagnetic assay. These different parts include a cryostat for operating the SQUID
at 77 K, excitation coils and alignment system to apply external magnetic field for
ac spectrometry and microfluidics for handling the biological samples. Fig. 3.8 shows
a photograph of the experimental set-up.
The SQUID gradiometer is operated inside a cryostat fabricated in-house. The cryo-
stat is made from nonmagnetic materials. The sensor chip sits on a sapphire rod in
direct contact with the liquid nitrogen. The liquid nitrogen reservoir is made out
of fiber glass is thermally decoupled from the environment by vacuum. A 250 µm
thick sapphire window on the polyvinyl chloride (PVC) vacuum shell separates the
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Figure 3.7: (a) The dimensions of the microfluidic channel and (b) a photograph
of completed PDMS chip enclosed by bonding a 100 µm thin PDMS cap layer.
77 K vacuum enclosed environment of the SQUID sensor from the room temperature
environment. The distance from the sensor to the top of the sapphire window is
less than 1 mm to allow strong coupling between the biomagnetic samples and the
superconducting pick-up coils of the gradiometer.
A Helmholtz coil with 20 turns and radius of 15 cm is used for producing a homo-
geneous magnetic field to excite MNPs. The Helmholtz coil is placed on a movable
frame and is manually aligned in order to minimize the coupling between the excita-
tion field and the pick-up loops of the SQUID. The microfluidic chip is placed on the
sapphire window for handling the samples. A peristaltic pump connected to reser-
voirs allows pumping a small sample volume to the microfluidics channel, which is
aligned to sit above the sensitive part of the pick-up coils of the SQUID gradiometer,
see Sec 3.4.2.1. Therefore, an alignment frame was designed which allows moving
of the microfluidic chip in the X-Y plane of the sapphire window above the SQUID.
Fig. 3.9 shows the designed frame, which is 3D-printed and mounted on the cryostat.
3.3.1 Ac susceptometry with SQUID gradiometer
Ac susceptometry is used to measure the change in size distribution of the MNPs. The
measurement technique involves magnetization of MNPs by an external ac magnetic
field and measuring the magnetization of the MNPs by the SQUID, see Sec. 2.2.2.
The ac susceptibility measurement set-up is shown in Fig. 3.8. A fluke AWG-220
waveform generator drives the Helmholtz coil creating a sinusoidal external excitation
field. The sample is pumped into the microchannel sitting on the sensitive part of
the SQUID gradiometer sensor. The SQUID signal is read out by Magnicon SEL-1
electronics in FLL mode. A Stanford SR-830 lock-in amplifier is used to extract
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Figure 3.8: A photograph of the experimental set-up and a close up top view of the
microchannel on the sapphire window. The SQUID is located under the 250 µm thick
sapphire window and the Helmholtz coil is aligned so that the SQUID is at the center
of the coil with highest field homogeneity. The small volumes of target analyte and
MNPs are then pumped in and out of the microchannel using the peristaltic pump.
Figure 3.9: An illustration of the designed microfluidic chip frame for precise align-
ment of the chip on the sensitive part of the sensor. A photograph of the 3D-printed
frame mounted on the cryostat holding the PDMS chip on the sapphire window above
the SQUID sensor.
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the real and imaginary components of the magnetic susceptibility from the SQUID
gradiometer signal having the excitation frequency as a reference. The excitation
field is in the range of 1 Hz to 10 kHz. In order to eliminate the residual coupling of
the excitation field to the pick-up coils, a calibration measurement is made without
having any samples. This calibration is considered the background and is subtracted
from all measurements with MNPs leaving only the response from the samples.
Upon binding of the MNPs with the RCA products, the hydrodynamic size of the
MNPs change and the frequency corresponding to the Brownian relaxation time of
the MNP changes, Fig. 2.3. Extracting the frequency and amplitude of the imaginary
susceptibility for the MNPs with and without any biological target can be used as the
parameter for the detection of the biological target. Introducing the target analyte
and specific binding of MNPs to it consequently changes the detection parameter,
i.e. the frequency and amplitude of the imaginary susceptibility.
3.4 Simulation
We evaluate the flux threading a pick-up loop produced by a MNP and calculate the
magnetic response from the MNP as a function of its positions within the pick-up
loop. First, we start with a single MNP and then we extend the calculation to the
flux from several hundreds of MNPs which are randomly distributed in the volume
of a microchannel. The MNP is considered a point-source particle with magnetic
moment m oriented at a random direction and placed at point r0. The dipole field
from the MNP at point r is:
H(r) = 14pi (
3(r− r0)−m · (r− r0)
|r− r0|5 −
m
|r− r0|3 ). (3.4)
More succinctly, we can define the dipole vector potential of the MNP at point r as:
Adip =
µ0
4pi
m× (r− r0)
|r− r0|3 (3.5)
and the magnetic flux threading the pick-up loop is
φ =
∮
Adip · dl (3.6)
where the integral is over the closed line of the pick-up loop, Fig. 3.10. In a field range
where the magnetic response of the particle is linear, the applied magnetic field is
much lower than the saturation field of the particles, the particles orient themselves
along the field lines. Having the magnetic moment of the MNP oriented along the
applied external field, the integral Eq.(3.6) provides the magnetic flux distribution
threading the pick-up loop as a function of the MNP’s position with respect to the
loop. Summing all the flux contributions from every single MNP gives the total flux
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Figure 3.10: Illustration of a single pick-up loop and the definition of coordinate
system and geometries.
from the colloidal MNP sample threading the pick-up loop. In the following sections,
we first calculate the flux from a single MNP threading a loop to provide an overall
picture of flux distribution as function of MNP position and excitation field direction.
We extend the simulations further by creating a particle system of hundreds of MNPs
randomly distributed within the geometry of our microfluidic channel and study the
flux threading the gradiometer sensor as a function of microchannel position.
3.4.1 A single point-source MNP
The MNPs inside the fabricated microchannel are distributed homogeneously inside
the volume of the channel. However, to make the simulations easier, we only assume
a single MNPas a point-source. In the following simulations we also assume that:
(I) the particle-particle interaction can be neglected, (II) the MNPs are thermally
blocked with constant magnetic moment, (III) the film thickness of the pick-up loops
is neglected and (IV) the external magnetic field magnetizes all the MNPs towards the
applied field direction and therefore, the point-source magnetization is also aligned
with the field. In the next section, we use randomly distributed MNPs in a volume
and sum all the flux contributions from every single MNP to calculate the total
flux from the colloidal MNP sample threading the pick-up loop. This also makes it
possible to study the effect of the channel geometry on the flux threading the pick-up
loop.
For simplicity, we first calculate the flux threading a single loop. The magnetic
moment of the MNPs with median size of 100 nm is about 4.8× 10−22 Am2 [1], and
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Figure 3.11: Normalized flux distribution from a point-source MNP at constant
distance of 1.1 mm from a sensing coil of 5 by 5 mm, sweeping the plane of the coil.
The magnetic excitation is in (a) x, (b) y and (c) z direction.
for the following simulations we assume we have 106 MNPs agglomerated to form a
single point-source MNP. The applied homogeneous magnetic field is aligned in x, y
and z directions magnetizing the point-source towards the field direction. Placing the
point-source MNP on the plane of the 5× 5 mm2 square loop with constant distance
z0, and integrating Eq.(3.6) over the closed line of the sensing coil, we calculate the
flux threading the coil. Fig. 3.11 shows the normalized magnetic flux distribution
Φ(r0)
Φmax(r0) produced by this point-source MNP threading the loop for external applied
field along x, y and z directions. The point-source sweeps the x-y plane and at each
point the flux threading the sensing coil is calculated. The color coding represents
the normalized amplitude of magnetic flux φ/φmax at each point.
For an applied magnetization field in the x or y direction, the maximum flux from the
dipole field of the point-source MNP is given when the particle is on the orthogonal
side lines of the sensing coil. If the applied magnetization is in z direction, placing
the magnetic particle at the center of the coil gives the maximum flux threading
the sensing loop. Since the excitation field of the Helmholtz coil is in plane of the
gradiometer sensor, the x and y magnetization are the relevant cases and we will only
study these two excitation directions.
Another parameter that is of interest is the area of the sensing coil. The maximum
magnetic flux threading the loop is calculated for an excitation field applied in either
the x or y direction and the results are shown in Fig. 3.12. The maximum flux is
calculated at different distances from the plane of the sensing coil versus the coil
area. For all distances to the coil plane, the flux increases with increasing loop size,
however, the maximum flux saturates for a particular area of the loop and it does
not depend on the area anymore. Thus, the maximum flux threading the loop not
only depends on the position of the point-source MNP but also on the size of the
pick-up loop area.
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Figure 3.12: Maximum flux from a point-source MNP versus the area of the sensing
loop for an excitation field in y direction and different distances between the MNP
and the plane of the loop.
3.4.2 Magnetic flux from a colloidal solution of MNPs
In reality the MNPs are not aggregated into a point-source but are suspended in the
volume of the microchannel. As it is evident from Fig. 3.12, at a constant loop area
the flux threading the loop decreases as nanoparticles move away from the plane of
the coil. In a colloidal sample, some of the MNPs are at the bottom of the channel
while some are furthest away on the top, therefore, it is more realistic to study the
magnetic flux through the pick-up coil due to a random distribution of suspended
particles in liquid. In order to simulate this colloidal solution, the MNPs are randomly
distributed in the 1× 1× 3 mm3 volume of the microchannel. Fig. 3.13(a) illustrates
the distribution of 100 MNPs inside the volume of the microfluidic channel, where
the bottom of the microchannel is placed at 1.1 mm distance from the plane of the
sensing loop. This is the physical distance between the SQUID sensor and the bottom
of the microfluidic channel. Having the magnetic excitation in the y direction the flux
distribution from the colloidal sample is calculated by summing the integral Eq.(3.6)
over the closed line of the coil for every single MNP inside the volume of the channel,
Fig. 3.13(b).
3.4.2.1 Magnetic flux of a colloidal sample threading a gradiometer
The sensor layout that we use does not have a single pick-up loop and is a first order
superconducting gradiometer which basically measures the difference in the flux lines
threading each loop. We have simulated the magnetic flux threading our gradiometer
sensor, Sec. 3.1.2, for a randomly distributed MNPs in 1 × 1 × 3 mm3 volume with
the bottom of the channel in plane with the gradiometer at a distance of 1.1 mm.
Fig. 3.14 shows the absolute value of the normalized flux difference | Φ1−Φ2(Φ1−Φ2)max | in
the two loops of the gradiometer versus the position of the microchannel.
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Figure 3.13: (a) Random distribution of MNPs in the 1 by 1 by 3 mm3 volume
of the microchannel at a constant distance of 1.1 mm above the plane of the 3 by 4
mm2 sensing loop. (b) Magnetic flux from the same sample threading the sensing
loop versus the position of the channel with the excitation field in the y direction.
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Figure 3.14: Absolute total flux difference threading the gradiometer sensor from
a colloidal sample in a microchannel of 1 by 1 by 3 mm3 volume. The center of
the channel sweeps the x-y plane of the gradiometer at a constant distance of 1.1
mm and the flux at each point is normalized to the maximum flux difference in the
gradiometer loops with the excitation field in y direction.
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The results show that to have the maximum signal from the sample, the channel
should be placed at the center line of the gradiometer. In this case, the magnetization
field lines from the sample go in the loop one and out of loop two and have opposite
signs. Since the gradiometer subtracts the fluxes from the two loops they add up
and we get the maximum flux from the sample at the center line of the gradiometer.
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Experimental Results
In this chapter, the experimental results from characterization of the MNPs and the
SQUID sensitivity to iron content are presented. The limit of detection (LOD) to
target analyte, the RCA coils, is estimated from magnetic ac susceptibility mea-
surements. The results include measurements of RCA coils and the agglutination of
MNPs with monomers from digested RCA coils.
4.1 Characterization of MNPs and system sensitiv-
ity
The ac magnetic susceptibility technique, as described in Sec. 2.2.2, is used to char-
acterize the MNPs. The volume and geometry of the magnetic fluid is fixed to 3
µl in volume using the microfluidic channel, Sec. 3.2. The filled channel is placed
above the most sensitive part of the gradiometer, and an external ac magnetic field
with frequency range of 1 to 10 kHz and field strength of 40 µT is applied to the
sample. The signal is measured using the SQUID gradiometer sensor. The MNPs
used in this part are the streptavidin-coateded MNPs with a median size of 100 nm
from Micromod (Micromod Partikeltechnologie GmbH, Rostock, Germany). The
in-phase and out-of-phase component of the SQUID signal acquired from samples
of various concentrations diluted in PBS versus the excitation field frequency are
shown in Fig. 4.1. The in-phase and out-of-phase components are related to the real
and imaginary components of the ac susceptibility, respectively. The imaginary part
of the susceptibility peaks at the Brownian relaxation frequency at around 80 Hz,
which corresponds to the median particle size of 100 nm according to Eq.(2.1). The
empirical Cole-Cole formula, Eq.(2.10), is used to accurately find the frequency of the
imaginary ac susceptibility peak. The amplitude of both real and imaginary parts of
the susceptibility decreases with decreasing the concentration of MNPs. There is no
frequency shift in the peak position of the imaginary part. Any shift in the position
of this peak frequency would translate into a change in the hydrodynamic size of the
MNPs, Eq.(2.1).
In order to extract the iron content sensitivity, different concentrations of the mag-
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Figure 4.1: (a) In-phase and (b) out-of-phase components of SQUID signal versus
the excitation field frequency for different concentrations of streptavidin-coateded
MNPs. Magnetic field strength is 40 µT. The in-phase and out-of-phase components
are related to the real and imaginary components of ac susceptibility, respectively.
The imaginary ac susceptibility peak position is at 80 Hz.
netic fluid with a constant volume of 3 µl was measured. Six different concentration,
from 1 mg/ml to 25 µg/ml of MNPs per unit volume were measured. The number
of MNPs in each concentration is estimated from the known number of particles per
unit volume: 6.0× 1012 particles per ml in a 10 mg/ml concentration.
Fig. 4.2 shows the linear relation between the amplitude of the peak out-of-phase com-
ponent and the number of MNPs. The vertical axis corresponds to the SQUID output
signal in the units of magnetic flux quanta. The extrapolation of this linear depen-
dence to the measured noise floor of the SQUID, 1.2× 10−5Φ0/√Hz, gives the esti-
mation of the magnetic content sensitivity of our system to be 1.5×106MNPs/√Hz
or 2.9× 10−10emu/√Hz in magnetic moment. This is equivalent to 2.5 ng of MNP.
This value is an important figure of merit as it is used to determine the sensitivity
of the magnetic bioassay.
4.2 Stability of the MNPs solutions
A sensitive biomagnetic assay with high sensitivity and specificity requires streptavidin-
coated MNP system which is colloidally stable. Measuring on samples with streptavidin-
coateded MNPs inside the microfluidic channel showed a loss of signal over time. This
loss of signal could be caused by either agglomeration of the streptavidin-coateded
MNPs, sedimentation of the particles inside the channel, or binding of the MNPs
to the surface of the PDMS channel. This phenomenon, however, was not observed
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Figure 4.2: The measured maximum out-of-phase signal as a function of number
of MNPs. The dashed-dotted lines are the signal to noise ratio (SNR) of 1 (1.2 ×
10−5Φ0/
√
Hz) and 10 (1.2× 10−4Φ0/√Hz).
for uncoated-MNPs. Since the reduction in the imaginary component of the ac sus-
ceptibility is the parameter we measure in order to detect the target analyte, any
instability in the colloidal solution would cause an error in the measurement, partic-
ularly at very low target concentrations.
In order to study the stability of the samples, we have measured the ac susceptibility
of both uncoated and streptavidin-coateded MNPs, Fig. 4.3. The channel was filled
with the fluidic sample and the ac susceptibility was measured 3 times without moving
the sample inside the microchannel. The results shows no substantial shift in the peak
frequency of the imaginary component and therefore the hydrodynamic size of the
MNPs has not changed or changes slower than the measurements time window of
the three subsequent measurements. There is, however, still some signal loss, which
is more pronounced in streptavidin-coateded MNPs than in the uncoated-MNPs.
To see the dynamical behaviour of this signal loss, the real and imaginary part of the
ac susceptibility at a frequency close to the peak amplitude of imaginary part was
measured for a duration of 12 minutes. The data points were taken every second for
both uncoated-MNPs and coated-MNPs and are plotted against time in Fig. 4.4 (a)
and (b), respectively. For the sample containing the uncoated-MNPs with median
size of 80 nm and concentration of 0.5 mg/ml both components of the ac susceptibil-
ity were measured at a frequency of 251 Hz. The two ac susceptibility components
change very insignificantly with time during the measurement. Measuring the ac
susceptibility of the streptavidin-coateded MNPs with 100 nm median size and 1.0
mg/ml concentration at a fixed frequency of 63 Hz as a function of time, however,
shows a continuous decrease. This constant decrease in signal with time is an is-
sue which needs to be addressed if the particle system is to be used as markers in
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Figure 4.3: Three consequent measurements of magnetic ac susceptibility for (a)
uncoated-MNP and (b) streptavidin-coated MNPs in the microfluidic channel.
biomagnetic assays.
Slopes of the lines in Fig. 4.4 define if the signal is increasing or decreasing over time.
The slope for both the real and imaginary component of the ac susceptibility from
the uncoated-MNPs is around 90 nV/s and positive. This means that it takes roughly
40 hours for this rate of change to affect the signal and increase it by 1%. The slopes
for the streptavidin-coateded MNPs are much larger and are roughly -1.12 µV/s and
-0.75 µV/s for real and imaginary components, respectively. Therefore, it takes 2.5
and 3 minutes for the real and imaginary components of the ac susceptibility to lose
1% of the signal, respectively. This is a much higher rate compared to the uncoated-
MNPs. This signal loss can be attributed to the streptavidin-coateding of the 100 nm
MNPs since the two particle system are the same otherwise. Streptavidin tends to
bind to the surface of the PDMS channel [66] that may result in the loss of the
signal. A possible solution is to coat the microfluidic channel with biocompatible
materials such as poly(ethylene oxide) (PEO) and poly(ethylene glycol) (PEG) to
avoid nonspecific binding of the streptavidin-coated MNPs to the surface [67].
4.3 Detection of RCA coils and determination of
target analyte limit of detection
The assay that is used in the following experiments is fully described in Sec. 2.1.
The final product of this assay is large DNA coils that have the sequence that
can be conjugated with the detection oligonucleotides. Upon hybridization of the
oligonucleotide-functionalized MNPs with these DNA coils, the hydrodynamic size
of the MNPs increases, and therefore their Brownian relaxation time changes. This
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Figure 4.4: The real and imaginary ac susceptibility of (a) uncoated-MNPs (median
size of 80 nm) and (b) streptavidin-coated MNPs (median size of 100 nm) measured
as a function of time at a constant frequency of 251 Hz and 63 Hz, respectively. The
real and imaginary parts of the ac susceptibility show very small change over time for
uncoated-MNPs while for streptavidin-coated particles they decrease as a function
of time.
process can be observed in two different ways. One in terms of observing a raise at a
low frequency with increasing RCA concentration. Since the conjugated MNPs with
DNA coils have large hydrodynamic volumes their Brownian relaxation frequency
are at very low frequencies, below 1 Hz. The other one is by means of measuring the
reduction of the peak amplitude of the imaginary part due to binding of MNPs to
large DNA coils.
Samples with various concentrations of RCA coils ranging from 0 to 30 pM (pico-
mole/l) were prepared and measured. The real and imaginary components of the
magnetic ac susceptibility are measured in the frequency range of 1 to 3000 Hz and
are shown in Fig. 4.5(a) and (b), respectively. The negative control (NC) sample
contains only functionalized MNPs with mass concentration of 50 µg/ml, and zero
concentration (0 pM) of RCA. According to the Cole-Cole formula Eq.(2.10), the
imaginary ac susceptibility component for the NC sample reaches a maximum at
60 Hz. This peak frequency (Brownian relaxation frequency) is lower compared with
non-functionalized MNPs due to the presence of oligonucleotides on the surface of
the MNPs. The functionalization increases the hydrodynamic volume and in turn
decreases the Brownian relaxation frequency (from 80 Hz to 60 Hz). Both the real
and imaginary ac susceptibility components decrease as the concentration of RCA
coils increases, see Fig. 4.5 (a) and (b), respectively.
The amplitude of both the real part at 1 Hz and the imaginary part at 60 Hz con-
tinuously decrease with increasing RCA concentration. This decrease is due to a
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Figure 4.5: (a) Real and (b) imaginary parts of the ac susceptibility as a function
of excitation frequency for different concentrations of RCA coils ranging from 0 (neg-
ative control NC) to 30 pM in a total volume of 3µL. The drop in the amplitude
of both real and imaginary components of the susceptibility indicates the increase
in the number of RCA coils and fewer numbers of unbound MNPs in the solution.
The red arrow shows a raise in the low frequency tail of the response with increasing
RCA concentration.
reduction of the number of free functionalized MNPs in the solution as for increasing
RCA concentration the functionalized MNPs are hybridized (and hence immobilized)
to the DNA coils. The effective hydrodynamic volume of the MNPs bound to very
large DNA coils increases and the Brownian relaxation frequency decreases well be-
low 10 Hz (the Brownian relaxation frequency of the 1 µm RCA coils is in the range
of 0.4 Hz). The red arrow in Fig. 4.5 (b) indicates this response. The increase in the
imaginary part of the magnetic susceptibility signal below 10 Hz may be due to the
appearance of this low frequency peak. The low frequency peak is more pronounced
for higher concentrations of RCA coils due to the greater ratio of bound MNPs to
free MNPs. It is also worth mentioning that there is a small increase in the frequency
of Brownian relaxation for higher RCA concentrations. This may be due to the fact
that larger MNPs in the sample distribution precede the smaller ones in hybridizing
with RCA coils [3].
The limit of detection for RCA coils is estimated by extracting the amplitudes of the
imaginary component of the ac susceptibility at 60 Hz for every RCA concentration.
The extinction is a difference between the peak amplitude of the NC sample (0
pM concentration) and the peak amplitudes of the RCA concentrations, χ′′NC −
χ′′C . Therefore, it determines the number of MNPs that were bound to the RCA
coils. Extrapolating the linear dependence of extinction to the noise floor of the
sensor corresponds to an estimated LOD of about 1.0× 105 RCA coils. This limit is
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Figure 4.6: The extinction signal (χ′′NC − χ′′C) for different concentrations of the
RCA coils at the peak frequency of 60 Hz as a function of number of RCA coils
in each corresponding concentration. The linear extrapolation gives a sensitivity of
1.0× 105 RCA coils in a 3 µL sample volume at SNR = 1.
equivalent to 66 fM of target analyte in the 3 µL sample volume, Fig. 4.6.
4.3.1 Estimation of number of MNPs per DNA coil
The ultimate sensitivity of the bioassay is determined by the iron content sensitivity
and by the number of MNPs per single DNA coil. In all samples with RCA coils
we had the same concentration of functionalized MNPs (50 µg/mL). Therefore, the
extinction of their ac susceptibility signal magnitude compared to the NC (the black
dotted line in Fig. 4.5 (a) and (b)) corresponds to the number of functionalized MNPs
bound to RCA coils. Using the slope, S, of the linear dependence of the signal to the
number of MNPs, Fig. 4.1, the remaining number of unbound functionalized MNPs,
NunbndC , is estimated and the number of functionalized MNPs bound to RCA coils,
N bndC , is:
NunbndC =
χ′′C
S
,
N bndC = NNC −NunbndC
(4.1)
where χ′′C is the maximum amplitude of the peak in the imaginary part of the ac
susceptibility for a RCA concentration of C and NNC is the number of particles in
the NC sample. Dividing the number of bound MNPs by the number of RCA coils
for each RCA concentration gives the average number of MNPs per RCA coil, gMNP :
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gMNP =
N bndC
NRCAC
= 1
NRCAC × S
(χ′′NC − χ′′C) (4.2)
where χ′′NC is the maximum amplitude of the peak in the imaginary part of the ac
susceptibility for NC sample and NRCAC is the number of RCA coils in the sample
with RCA coil concentration of C. The estimated gMNP from the lowest to the
highest concentration of RCA coils ranges from 3.6 to 1.3 MNPs per coil. We obtain
on average 2 MNPs per RCA coil, which is a close estimation to the evaluated mean
value of 3 MNP per RCA coil using the DynoMag system [3]. Analysing the RCA
coils conjugated with 130 nm MNPs using transmission electron microscopy (TEM)
also shows that the average number of MNPs per coil is around 2 [68].
4.4 MNP agglutination experiments
The monomers produced from digesting the RCA coils were used for the identifi-
cation of the target analyte. The assay is described in Sec. 2.1.6 and we measure
the agglutination of MNPs by monomers using magnetic ac susceptibility. Upon the
introduction of monomers, the two MNP probes start to agglomerate as they each
can only conjugate to one side of the monomer sequence. The agglomeration cre-
ates agglutinated clusters of MNPs with large hydrodynamic volume. The change
in this hydrodynamic volume is then detected by magnetic ac susceptibility. For
this purpose, two identical MNP systems (100 nm in median size) are functional-
ized with two oligonucleotides which match different regions of the padlock probe.
These functionalized MNPs are detection probes and link together in the presence
of monomers inducing an agglutination. The clustering of MNPs due to the pres-
ence of the monomers is then measured using ac susceptibility. The detection and
quantification of the agglutinated probes is determined by measuring the change in
the imaginary part of the ac susceptibility. Fig. 4.7 shows the imaginary part of
the ac susceptibility as a function of frequency for different monomer concentrations.
The NC sample with 0 nM concentration of monomers has equal amounts of solid
content from the two MNPs probes with a total solid content concentration of 200
µg/ml. The NC sample is used as a reference. The three samples with monomer
concentration of: 23, 46 and 227 nM are also prepared with the same solid content of
the two probes. The aggregation of the two probes in the presence of the monomers
forms clusters with large hydrodynamic size. Therefore, their response lags behind
the external applied field at lower frequencies. In this case, a decrease in the peak
amplitude of the imaginary susceptibility and an increase at lower frequency is ob-
served. The decrease in the peak amplitude is due to the clustering of the two MNP
probes and the raise at the low frequency is due to the larger hydrodynamic size of
the agglutinated clusters.
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Figure 4.7: Imaginary ac susceptibility as a function of applied excitation field for
0 nM (negative control) and three different concentration of monomers: 23, 46 and
227 nM.
Although by increasing the monomer concentration one would expect to see more ag-
glomeration, the opposite effect is observed. This is because the number of monomers
is much larger compared to the number of two probe MNPs that instead of increasing
the probability of clustering between the probes they occupy all available sites on the
particles making them less likely to agglomerate. For example, in the sample with
227 nM monomer concentration, there are 300 monomers available per single MNP
probe, thus, the monomers attach to almost all available sites on both MNP probes
making it less likely for the two probes to agglomerate. The large error bars at low
frequency (below 10 Hz) is from the MNP clusters formed from agglutination. The
large size of the clusters make them colloidally unstable and they immobilize inside
the channel. This can be observed dynamically by consequently measuring on the
sample which is resting inside the microfluidic channel. Fig. 4.8 shows three conse-
quent measurements of 23 nM monomer concentration in a span of an hour. Below
10 Hz, the amplitude of the imaginary susceptibility drops down over time while the
peak amplitude keeps the same amplitude.
4.4.1 Magnetic incubation of monomers
To increase the chance of the two probes meeting and agglutinating in the presence
of the monomers, magnetic incubation can be used. A magnetic incubation is done
by placing the incubating sample on a magnet. The collection of the suspended
MNPs over the magnet increases the chance of the two probes meeting and forming
a cluster. The magnet that was used in these experiments is a small block magnet
with a surface field of 650 mT. Two different magnetic incubation protocols have
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Figure 4.8: Real and imaginary ac susceptibility versus applied magnetic excitation
frequency of a sample containing 23 nM monomers, measured 3 times in a row. The
sample was pumped inside the microfluidic channel and was not moved during the
three measurements. The blue curve is measured right after filling the microfluidic
channel followed by the second and third measurements, red and yellow curves re-
spectively. Each measurement takes roughly 20 minutes therefore, the figure shows
how the imaginary susceptibility below 10 Hz changes over time.
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Figure 4.9: (a) The real and imaginary magnetic susceptibility versus excitation
field frequency from samples with 0 and 23 nM monomers incubated (a) without any
applied field and (b) within external dc field for 30 minutes. There is a slight shift
in the peak amplitude frequency of the NC sample due to magnetic incubation, from
100 Hz to 79 Hz.
been used and compared. In the first incubation protocol the sample is incubated in
the presence of the magnetic field for 30 minutes. The NC samples are also incubated
with the magnet. Fig. 4.9 shows the results from a sample with 23 nM monomer
concentration which was (a) incubated without magnet and (b) in the presence of
the magnet. The drops in the peak of imaginary susceptibility are 400 and 725 µV
for the incubation without and with magnet, respectively.
The second protocol for magnetic incubation does not use the magnet during the
whole 30 minutes of incubation. In this protocol, the incubation is carried out with-
out the magnet for the first 28 minutes and then for only 1 minute the sample is
placed on a magnet collecting all the suspended MNPs on it. The final minute is
given for the re-suspension of the MNPs in the solution. The NC samples also fol-
lowed the same incubation protocol. The ac susceptibility of samples with 0 and
23 nM monomer concentration is plotted in Fig. 4.10. Using this protocol, no shift in
the frequency of the imaginary susceptibility peak amplitude was observed and the
drop of the amplitude was around 1261 µV which is 3 times more than the value ob-
tained from the incubation without any magnets. Therefore, applying magnetic field
during incubation, improves the hybridization kinetics and significantly increases the
signals from the samples. Further studies are required to find the optimal incubation
condition to maximize the drop in the peak amplitude of the imaginary susceptibility.
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Figure 4.10: Ac magnetic susceptibility measured as a function of frequency for
monomer samples with 0 and 23 nM concentration. The samples were incubated
inside an applied magnetic field for only 1 minute.
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Conclusions
A magnetic bioassay based on a high-T c SQUID gradiometer sensor was demon-
strated to have an excellent limit of detection. The DNA assay implements RCA as
an amplification technique for the detection of DNA target molecules. The magnetic
ac susceptibility measurement was used to detect the specific binding of the MNP
markers to the target DNA molecule. An advantage of using the ac susceptibility
is very low background signal. The detection signal is the imaginary component of
the ac susceptibility and comes only from the MNPs response. The measurements
of the liquid suspended MNPs in the microfluidic chip show an ultimate magnetic
sensitivity of 2.5 ng and leads to a LOD to DNA target analyte of 0.2× 10−18 mole.
The LOD is comparable to the state-of-the-art ELISA assays [69]. However, our
magnetic assay is much faster (2 hours) and does not require multiple washing steps.
The ultra-high sensitivity combined with short turn-around-time is promising for
applications in future POC diagnostic system, where all steps of the assay are im-
plemented on a disposable lab-on-a-chip. The assay is not limited to a single tar-
get molecule and can be adopted for various DNA and RNA targets. One of the
drawbacks, however, is the need for liquid nitrogen to operate our high-T c SQUID.
Recently, we have demonstrated the successful operation and noise measurements of
a high-T c SQUID utilizing a commercial two stage micro electro mechanical system
(MEMS) based Joule-Thomson micro-cooler, from Kryoz Technologies BV [2]. The
micro-cooler offers long operation time, simple usage, and temperature stability and
adjustment. It can also be integrated with the disposable lab-on-a-chip microfluidic
sample handler. The magnetic bioassay is therefore very promising for implementa-
tion in future POC diagnostic systems.
5.1 Outlook
The biosensing sensitivity of our magnetic bioassay is determined by the sensitivity
of the magnetic readout and the number of MNPs conjugated per single RCA coil.
Increasing the excitation field amplitude would proportionally increase the magnetic
43
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sensitivity of our ac susceptibility system and consequently the LOD to target ana-
lyte. An estimated number of 2 MNPs per coil was calculated for the current assay.
However, there are many more sites available for binding of the MNPs. Understand-
ing the kinetics of MNP hybridization with RCA coils could help to improve the
number of MNPs per RCA coil. Increasing the number of amplification steps by
applying the C2CA protocol would also increase the sensitivity to target analyte.
This would, however, increase the total turnaround time of the bioassay.
Although the magnetic bioassay presented here has an excellent performance, it is
still far from practical applications. Further work is required on tackling the remain-
ing issues before the assay is ready for practical field applications. Major obstacles
include replacing the liquid nitrogen with a closed cycle dry cooler and the full im-
plementation of the assay on a lab-on-a-chip.
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